Cystatin C Concentration as a Predictor of Systolic and Diastolic Heart Failure

Journal of Cardiac Failure

Volumn 14, Issue 1, 2008, Pages 19-26

  Moran, Andrew ^a,b   Katz, Ronit ^c   Smith, Nicolas L ^c,d   Fried, Linda F ^e   Sarnak, Mark J ^f   Seliger, Stephen L ^g   Psaty, Bruce ^c,d   Siscovick, David S ^c,d   Gottdiener, John S ^h   Shlipak, Michael G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e Veteran Affairs Pittsburgh Health Care System   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cystatin C; diastolic heart failure; ejection fraction; elderly; estimated glomerular filtration rate; heart failure; systolic heart failure

Indexed keywords

CYSTATIN C;

AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; DISEASE MARKER; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC HEART FAILURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; CONFIDENCE INTERVALS; CYSTATINS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SURVIVAL ANALYSIS;

EID: 38349103706     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.09.002     Document Type: Article

References (39)

1. Bibbins-Domingo K., Lin F., Vittinghoff E., Barrett-Connor E., Hulley S.B., Grady D., et al. Predictors of heart failure among women with coronary disease. Circulation 110 (2004) 1424-1430
2. Gottdiener J.S., Arnold A.M., Aurigemma G.P., Polak J.F., Tracy R.P., Kitzman D.W., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 (2000) 1628-1637
3. Chae C.U., Albert C.M., Glynn R.J., Guralnik J.M., and Curhan G.C. Mild renal insufficiency and risk of congestive heart failure in men and women > or = 70 years of age. Am J Cardiol 92 (2003) 682-686
4. Sarnak M.J., Katz R., Stehman-Breen C.O., Fried L.F., Jenny N.S., Psaty B.M., et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142 (2005) 497-505
5. Coll E., Botey A., Alvarez L., Poch E., Quinto L., Saurina A., et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36 (2000) 29-34
6. Fliser D., and Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 37 (2001) 79-83
7. Bibbins-Domingo K., Chertow G.M., Fried L.F., Odden M.C., Newman A.B., Kritchevsky S.B., et al. Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study. Arch Intern Med 166 (2006) 1396-1402
8. Stewart G.A., Gansevoort R.T., Mark P.B., Rooney E., McDonagh T.A., Dargie H.J., et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 67 (2005) 217-226
9. Ix J.H., Shlipak M.G., Chertow G.M., Ali S., Schiller N.B., and Whooley M.A. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail 12 (2006) 601-607
10. Levin A., Thompson C.R., Ethier J., Carlisle E.J., Tobe S., Mendelssohn D., et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34 (1999) 125-134
11. Paoletti E., Bellino D., Cassottana P., Rolla D., and Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 46 (2005) 320-327
12. McMahon L.P., Roger S.D., and Levin A. Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol 15 (2004) 1640-1647
13. London G.M., Guerin A.P., Marchais S.J., Metivier F., Pannier B., and Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18 (2003) 1731-1740
14. Goodman W.G., London G., Amann K., Block G.A., Giachelli C., Hruska K.A., et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis 43 (2004) 572-579
15. Ohya Y., Iseki K., Iseki C., Miyagi T., Kinjo K., and Takishita S. Increased pulse wave velocity is associated with low creatinine clearance and proteinuria in a screened cohort. Am J Kidney Dis 47 (2006) 790-797
16. Fried L.P., Borhani N.O., Enright P., Furberg C.D., Gardin J.M., Kronmal R.A., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1 (1991) 263-276
17. Erlandsen E.J., Randers E., and Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59 (1999) 1-8
18. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
19. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 Suppl 1 (2002) S1-S266
20. Shlipak M.G., Katz R., Fried L.F., Jenny N.S., Stehman-Breen C.O., Newman A.B., et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 45 (2005) 268-271
21. Psaty B.M., Kuller L.H., Bild D., Burke G.L., Kittner S.J., Mittelmark M., et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5 (1995) 270-277
22. Ives D.G., Fitzpatrick A.L., Bild D.E., Psaty B.M., Kuller L.H., Crowley P.M., et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5 (1995) 278-285
23. Lunn M., and McNeil D. Applying Cox regression to competing risks. Biometrics 51 (1995) 524-532
24. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
25. Gardin J.M., Siscovick D., Anton-Culver H., Lynch J.C., Smith V.E., Klopfenstein H.S., et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation 91 (1995) 1739-1748
26. Schrier R.W. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006) 1-8
27. Cody R.J., Atlas S.A., Laragh J.H., Kubo S.H., Covit A.B., Ryman K.S., et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78 (1986) 1362-1374
28. Dries D.L., Exner D.V., Domanski M.J., Greenberg B., and Stevenson L.W. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 681-689
29. Hostetter T.H. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351 (2004) 1344-1346
30. Eriksson P., Deguchi H., Samnegard A., Lundman P., Boquist S., Tornvall P., et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 24 (2004) 551-557
31. Smith G.L., Lichtman J.H., Bracken M.B., Shlipak M.G., Phillips C.O., DiCapua P., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47 (2006) 1987-1996
32. Shlipak M.G. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138 (2003) 917-924
33. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med 327 (1992) 685-691
34. Klahr S., Levey A.S., Beck G.J., Caggiula A.W., Hunsicker L., Kusek J.W., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330 (1994) 877-884
35. Maschio G., Alberti D., Janin G., Locatelli F., Mann J.F., Motolese M., et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334 (1996) 939-945
36. Ruggenenti P., Perna A., Loriga G., Ganeva M., Ene-Iordache B., Turturro M., et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 365 (2005) 939-946
37. Wright Jr. J.T., Bakris G., Greene T., Agodoa L.Y., Appel L.J., Charleston J., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288 (2002) 2421-2431
38. Davis B.R., Piller L.B., Cutler J.A., Furberg C., Dunn K., Franklin S., et al. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 113 (2006) 2201-2210
39. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269